| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/08/2001 | EP1121354A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3? agonists or antagonists |
| 08/08/2001 | EP1121351A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 08/08/2001 | EP1121345A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1- 2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121142A2 Angiogenically effective unit dose of fgf-2 and method of use |
| 08/08/2001 | EP1121141A2 Angiogenically effective unit dose of fgf and method of administering |
| 08/08/2001 | EP1121129A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 08/08/2001 | EP1121121A2 Methods for inhibiting diabetic complications |
| 08/08/2001 | EP1121116A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121101A1 Aerosol ointment compositions and method of manufacture |
| 08/08/2001 | EP1121099A1 Pharmaceutical composition with gastric residence and controlled release |
| 08/08/2001 | EP0841918B1 Thrombin inhibitors |
| 08/08/2001 | EP0798298B1 Thiazolidinone or oxazolidinone derivatives to treat angina pectoris or compositions containing the same as active ingredient |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307632A Ependymal neural stem cells and method for their isolation |
| 08/08/2001 | CN1307571A Guanidine derivatives |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307522A Multi-action particle for structuring biological media |
| 08/08/2001 | CN1306839A Notoginseng flower capsule |
| 08/08/2001 | CN1306829A Medicine for treating cerbrovascular disease and its sequelae |
| 08/08/2001 | CN1306777A Blood pressure lowering soup and powder |
| 08/08/2001 | CN1069323C Gaseous polymerization method |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069309C N-(aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application thereof |
| 08/07/2001 | USRE37314 Pyrimidine derivatives |
| 08/07/2001 | US6271393 Process for producing N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 08/07/2001 | US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 08/07/2001 | US6271249 Diphenyl imidazoles as potassium channel modulators |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy |
| 08/07/2001 | US6271228 Blood pressure stabilization during hemodialysis |
| 08/07/2001 | US6271223 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 08/07/2001 | US6271201 Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I |
| 08/07/2001 | US6271199 Treatment of infarcts |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270779 Nitric oxide-releasing metallic medical devices |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | CA2191101C Materials and methods for treatment of plaquing diseases |
| 08/07/2001 | CA2075718C Crf analogs |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055692A2 Neurosteroids as markers for alzheimer's disease |
| 08/02/2001 | WO2001055432A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055221A1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055153A1 Clavams as protease inhibitors |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055147A1 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055133A1 Substituted tryptophan derivatives |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055120A1 Preparation of sulfonamides |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001055103A2 Chimeric neuropeptide y receptors |
| 08/02/2001 | WO2001055098A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 08/02/2001 | WO2001055078A1 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
| 08/02/2001 | WO2001054748A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
| 08/02/2001 | WO2001054730A1 METHOD FOR PRODUCING A COENZYME Q10 / η-CYCLODEXTRIN COMPLEX |
| 08/02/2001 | WO2001054726A1 REMEDIES FOR REPERFUSION INJURY CONTAINING INTEGRIN αvβ3 ANTAGONIST |
| 08/02/2001 | WO2001054699A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054686A2 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 08/02/2001 | WO2001054682A1 Remedies |
| 08/02/2001 | WO2001054677A2 Ace inhibitor-vasopressin antagonist combinations |
| 08/02/2001 | WO2001054669A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 08/02/2001 | WO2001054668A1 Pharmaceutical compositions comprising a hmg reductase inhibitor |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001018048A3 Smooth muscle cell promoter and uses thereof |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO1999066918A8 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 08/02/2001 | US20010011146 Pevention cell degradation |
| 08/02/2001 | US20010011126 Isolated protein; genetic engineering |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011081 Pharmaceutical composition comprising L- carnitine or alkanoyl L-carnitine for the prevention and treatment of diseases brought about by lipid metabolism disorders |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011074 Antiischemic agents; cardiovascular disorders |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |